Differential expression and HIV-1 regulation of μ-opioid receptor splice variants across human central nervous system cell types

Journal of NeuroVirology

Volumn 18, Issue 3, 2012, Pages 181-190

  Dever, Seth M ^a   Xu, Ruqiang ^a   Fitting, Sylvia ^a   Knapp, Pamela E ^a   Hauser, Kurt F ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Astroglia; HIV 1; Microglia; MOR OPRM1; Opiate drug abuse; Splice variant

Indexed keywords

CALCIUM; MESSENGER RNA; MORPHINE; MU 1 OPIATE RECEPTOR; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR 1A; MU OPIATE RECEPTOR 1X; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ARTICLE; BRAIN NERVE CELL; CELL STRAIN HEK293; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IN VITRO STUDY; MACROGLIA; MICROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ALTERNATIVE SPLICING; ASTROCYTES; COGNITION; GENE EXPRESSION REGULATION; HEK293 CELLS; HIV INFECTIONS; HIV-1; HUMANS; MICROGLIA; MORPHINE; NEURONS; ORGAN SPECIFICITY; PROTEIN ISOFORMS; RECEPTORS, OPIOID, MU; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84863644931     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-012-0096-z     Document Type: Article

References (58)

1. Abbadie C, Pan Y, Drake CT, Pasternak GW (2000) Comparative. immunohistochemical distributions of carboxy terminus epitopes. from the mu-opioid receptor splice variants MOR-1D, MOR-1 and. MOR-1C in the mouse and rat CNS. Neuroscience 100:141-153. (Pubitemid 30670308)
2. Adler MW, Geller EB, Rogers TJ, Henderson EE, Eisenstein TK. (1993) Opioids, receptors, and immunity. Adv Exp Med Biol. 335:13-20. (Pubitemid 23294289)
3. Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE (2005). Does drug abuse alter microglial phenotype and cell turnover in. the context of advancing HIV infection? Neuropathol Appl Neurobiol. 31:325-338. (Pubitemid 40769531)
4. Arango JC, Simmonds P, Brettle RP, Bell JE (2004) Does drug abuse. influence the microglial response in AIDS and HIV encephalitis?. AIDS 18(SUPPL. 1):S69-S74. (Pubitemid 38365908)
5. Bare LA, Mansson E, Yang D (1994) Expression of two variants of the. human mu opioid receptor mRNA in SK-N-SH cells and human. brain. FEBS Lett 354:213-216. (Pubitemid 24335510)
6. Bass NH, Hess HH, Pope A, Thalheimer C (1971) Quantitative. cytoarchitectonic distribution of neurons, glia, and DNA in rat. cerebral cortex. J Comp Neurol 143:481-490.
7. Bell JE, Brettle RP, Chiswick A, Simmonds P (1998) HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain 121(Pt 11):2043-2052. (Pubitemid 28497903)
8. Beltran JA, Pallur A, Chang SL (2006) HIV-1 gp120 up-regulation of. the mu opioid receptor in TPA-differentiated HL-60 cells. Int. Immunopharmacol 6:1459-1467. (Pubitemid 44038689)
9. Bidlack JM (2000) Detection and function of opioid receptors on cells. from the immune system. Clin Diagn Lab Immunol 7:719-723.
10. Burbassi S, Sengupta R, Meucci O (2010) Alterations of CXCR4. function in mu-opioid receptor-deficient glia. Eur J Neurosci. 32:1278-1288.
11. Cadet P, Weeks BS, Bilfinger TV, Mantione KJ, Casares F, Stefano GB. (2001) HIV gp120 and morphine alter mu opiate receptor expression. in human vascular endothelium. Int J Mol Med 8:165-169.
12. Chao CC, Gekker G, Sheng WS, Hu S, Peterson PK (2001) U50488.inhibits HIV-1 expression in acutely infected monocyte-derived. macrophages. Drug Alcohol Depend 62:149-154. (Pubitemid 32195505)
13. Chen C, Li J, Bot G, Szabo I, Rogers TJ, Liu-Chen LY (2004). Heterodimerization and cross-desensitization between the muopioid. receptor and the chemokine CCR5 receptor. Eur J Pharmacol. 483:175-186. (Pubitemid 38068398)
14. Conklin BR, Farfel Z, Lustig KD, Julius D, Bourne HR (1993) Substitution. of three amino acids switches receptor specificity of Gq. alpha to that of Gi alpha. Nature 363:274-276. (Pubitemid 23158533)
15. Donahoe RM, Vlahov D (1998) Opiates as potential cofactors in. progression of HIV-1 infections to AIDS. J Neuroimmunol. 83:77-87. (Pubitemid 28280954)
16. El-Hage N, Gurwell JA, Singh IN, Knapp PE, Nath A, Hauser KF. (2005) Synergistic increases in intracellular Ca2+, and the release. of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates. and HIV-1 Tat. Glia 50:91-106. (Pubitemid 40695264)
17. El-Hage N, Bruce-Keller AJ, Yakovleva T, Bazov I, Bakalkin G, Knapp PE, Hauser KF (2008) Morphine exacerbates HIV-1 Tatinduced. cytokine production in astrocytes through convergent. effects on [Ca2+]i, NF-?B trafficking and transcription. PLoS. One 3:e4093.
18. Fitting S, Zou S, ChenW, Vo P, Hauser KF, Knapp PE (2010) Regional. heterogeneity and diversity in cytokine and chemokine production. by astroglia: differential responses to HIV-1 Tat, gp120, and. morphine revealed by multiplex analysis. J Proteome Res. 9:1795-1804.
19. Grimm MC, Ben-Baruch A, Taub DD, Howard OM, Resau JH, Wang. JM, Ali H, Richardson R, Snyderman R, Oppenheim JJ (1998). Opiates transdeactivate chemokine receptors: delta and mu opiate. receptor-mediated heterologous desensitization. J Exp Med. 188:317-325. (Pubitemid 28357760)
20. Gris P, Gauthier J, Cheng P, Gibson DG, Gris D, Laur O, Pierson J, Wentworth S, Nackley AG, Maixner W, Diatchenko L (2010) A. novel alternatively spliced isoform of the mu-opioid receptor:. functional antagonism. Mol Pain 6:33.
21. Gurwell JA, Nath A, Sun Q, Zhang J, Martin KM, Chen Y, Hauser KF. (2001) Synergistic neurotoxicity of opioids and human immunodeficiency. virus-1 Tat protein in striatal neurons in vitro. Neuroscience. 102:555-563. (Pubitemid 32171876)
22. Hauser KF, El-Hage N, Buch S, Berger JR, Tyor WR, Nath A, Bruce-Keller AJ, Knapp PE (2005) Molecular targets of opiate drug. abuse in neuroAIDS. Neurotox Res 8:63-80.
23. Hauser KF, El-Hage N, Stiene-Martin A,MaragosWF, Nath A, Persidsky. Y, Volsky DJ, Knapp PE (2007) HIV-1 neuropathogenesis: glial. mechanisms revealed through substance abuse. J Neurochem. 100:567-586. (Pubitemid 46095610)
24. Heinisch S, Kirby LG (2009) Fractalkine/CX3CL1 enhances GABA. synaptic activity at serotonin neurons in the rat dorsal raphe. nucleus. Neuroscience 164:1210-1223.
25. Kao SC, Zhao X, Lee CY, Atianjoh FE, Gauda EB, Yaster M, Tao YX. (2012) Absence of mu opioid receptor mRNA expression in astrocytes. and microglia of rat spinal cord. Neuroreport 23:378-384.
26. Koch T, Schulz S, Pfeiffer M, Klutzny M, Schroder H, Kahl E, Hollt V. (2001) C-terminal splice variants of the mouse mu-opioid receptor. differ in morphine-induced internalization and receptor resensitization. J Biol Chem 276:31408-31414. (Pubitemid 37385013)
27. Li Y, Merrill JD, Mooney K, Song L, Wang X, Guo CJ, Savani RC, Metzger DS, Douglas SD, Ho WZ (2003) Morphine enhances. HIV infection of neonatal macrophages. Pediatr Res 54:282-288. (Pubitemid 36918165)
28. Liu XY, Liu ZC, Sun YG, Ross M, Kim S, Tsai FF, Li QF, Jeffry J, Kim JY, Loh HH, Chen ZF (2011) Unidirectional cross-activation. of GRPR by MOR1D uncouples itch and analgesia induced by. opioids. Cell 147:447-458.
29. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression. data using real-time quantitative PCR and the 2(?delta delta C(T)). method. Methods 25:402-408. (Pubitemid 34164012)
30. Morgello S, Gelman BB, Kozlowski PB, Vinters HV, Masliah E, Cornford M, Cavert W, Marra C, Grant I, Singer EJ (2001) The. National NeuroAIDS Tissue Consortium: a new paradigm in brain. banking with an emphasis on infectious disease. Neuropathol. Appl Neurobiol 27:326-335. (Pubitemid 32758619)
31. Nath A, Anderson C, Jones M, Maragos W, Booze R, Mactutus C, Bell. J, Hauser KF, Mattson M(2000) Neurotoxicity and dysfunction of. dopaminergic systems associated with AIDS dementia. J Psychopharmacol. 14:222-227.
32. Nath A, Hauser KF, Wojna V, Booze RM, Maragos W, Prendergast M, Cass W, Turchan JT (2002) Molecular basis for interactions of. HIV and drugs of abuse. J Acquir Immune Defic Syndr 31(SUPPL. 2):S62-S69. (Pubitemid 35190560)
33. Nedergaard M, Ransom B, Goldman SA (2003) New roles for astrocytes:. redefining the functional architecture of the brain. Trends. Neurosci 26:523-530. (Pubitemid 37176906)
34. Pan YX, Xu J, Mahurter L, Xu M, Gilbert AK, Pasternak GW (2003). Identification and characterization of two new human mu opioid. receptor splice variants, hMOR-1O and hMOR-1X. Biochem. Biophys Res Commun 301:1057-1061. (Pubitemid 36279220)
35. Peterson PK, Sharp BM, Gekker G, Portoghese PS, Sannerud K, Balfour. HH Jr (1990) Morphine promotes the growth of HIV-1 in human. peripheral blood mononuclear cell cocultures. AIDS 4:869-873. (Pubitemid 20342117)
36. Peterson PK, Gekker G, Schut R, Hu S, Balfour HH Jr, Chao CC. (1993) Enhancement of HIV-1 replication by opiates and cocaine:. the cytokine connection. Adv Exp Med Biol 335:181-188. (Pubitemid 23294312)
37. Peterson PK, Hu S, Anderson WR, Chao CC (1994) Nitric oxide. production and neurotoxicity mediated by activated microglia. from human versus mouse brain. J Infect Dis 170:457-460. (Pubitemid 24226382)
38. Peterson PK, Molitor TW, Chao CC (1998) The opioid-cytokine connection. J Neuroimmunol 83:63-69. (Pubitemid 28280952)
39. Peterson PK, Gekker G, Lokensgard JR, Bidlack JM, Chang AC, Fang. X, Portoghese PS (2001) Kappa-opioid receptor agonist suppression. of HIV-1 expression in CD4+ lymphocytes. Biochem Pharmacol. 61:1145-1151. (Pubitemid 32285481)
40. Podhaizer EM, Zou S, Fitting S, Samano KL, El-Hage N, Knapp PE, Hauser KF (2011) Morphine and gp120 toxic interactions in. striatal neurons are dependent on HIV-1 strain. J Neuroimmune. Pharmacol. doi:10.1007/s11481-011-9326-z.
41. Putney JW (2012) Calcium signaling: deciphering the calcium-NFAT. pathway. Curr Biol 22:R87-R89.
42. Ravindranathan A, Joslyn G, Robertson M, Schuckit MA, Whistler JL, White RL (2009) Functional characterization of human variants of. the mu-opioid receptor gene. Proc Natl Acad Sci U S A. 106:10811-10816.
43. Regan PM, Dave RS, Datta PK, Khalili K (2011) Epigenetics of ?-opioid receptors: intersection with HIV-1 infection of the central. nervous system. J Cell Physiol 227:2832-2841.
44. Rogers TJ, Peterson PK (2003) Opioid G protein-coupled receptors:. signals at the crossroads of inflammation. Trends Immunol. 24:116-121. (Pubitemid 36263094)
45. Rogers TJ, Steele AD, Howard OM, Oppenheim JJ (2000) Bidirectional. heterologous desensitization of opioid and chemokine. receptors. Ann N Y Acad Sci 917:19-28.
46. Roy S, Wang J, Kelschenbach J, Koodie L, Martin J (2006) Modulation. of immune function by morphine: implications for susceptibility to. infection. J Neuroimmune Pharmacol 1:77-89. (Pubitemid 44257502)
47. Schnell SA, Wessendorf MW (2009) Lack of evidence for the muopioid. receptor splice variant MOR1C in rats. J Comp Neurol. 517:452-458.
48. Schwartz JP, Nishiyama N, Wilson D, Taniwaki T (1994) Receptormediated. regulation of neuropeptide gene expression in astrocytes. Glia 11:185-190. (Pubitemid 2116313)
49. Sharp BM, Roy S, Bidlack JM (1998) Evidence for opioid receptors on. cells involved in host defense and the immune system. J Neuroimmunol. 83:45-56. (Pubitemid 28280950)
50. Sharp BM, McAllen K, Gekker G, Shahabi NA, Peterson PK (2001). Immunofluorescence detection of delta opioid receptors (DOR). on human peripheral blood CD4+ T cells and DOR-dependent. suppression of HIV-1 expression. J Immunol 167:1097-1102. (Pubitemid 32660870)
51. Stiene-Martin A, Hauser KF (1991) Glial growth is regulated by. agonists selective for multiple opioid receptor types in vitro. J. Neurosci Res 29:538-548.
52. Stiene-Martin A, Zhou R, Hauser KF (1998) Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappaopioid. receptor expression among cultured mouse astrocytes. Glia. 22:249-259. (Pubitemid 28159016)
53. Stiene-Martin A, Knapp PE, Martin K, Gurwell JA, Ryan S, Thornton. SR, Smith FL, Hauser KF (2001) Opioid system diversity in. developing neurons, astroglia, and oligodendroglia in the subventricular. zone and striatum: impact on gliogenesis in vivo. Glia. 36:78-88.
54. Suzuki M, El-Hage N, Zou S, Hahn YK, Sorrell ME, Sturgill JL, Conrad DH, Knapp PE, Hauser KF (2011) Fractalkine/CX3CL1. protects striatal neurons from synergistic morphine and HIV-1. Tat-induced dendritic losses and death. Mol Neurodegener 6:78.
55. Tran PB, Ren D, Miller RJ (2005) The HIV-1 coat protein gp120. regulates CXCR4-mediated signaling in neural progenitor cells. J Neuroimmunol 160:68-76. (Pubitemid 40248595)
56. Turchan-Cholewo J, Dimayuga FO, Ding Q, Keller JN, Hauser KF, Knapp PE, Bruce-Keller AJ (2008) Cell-specific actions of HIVTat. and morphine on opioid receptor expression in glia. J Neurosci. Res 86:2100-2110.
57. Turchan-Cholewo J, Dimayuga FO, Gupta S, Keller JN, Knapp PE, Hauser KF, Bruce-Keller AJ (2009) Morphine and HIV-Tat increase. microglial-free radical production and oxidative stress:. possible role in cytokine regulation. J Neurochem 108:202-215.
58. Zou S, Fitting S, Hahn YK, Welch SP, El-Hage N, Hauser KF, Knapp. PE (2011) Morphine potentiates neurodegenerative effects of. HIV-1 Tat through actions at mu-opioid receptor-expressing glia. Brain 134:3616-3631